HIV and SIV CTL escape: implications for vaccine design (original) (raw)

• Finzi, D. et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Med. 5, 512–517 (1999).
  Article CAS PubMed Google Scholar
• Koup, R. A. et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650–4655 (1994).
  CAS PubMed PubMed Central Google Scholar
• Borrow, P., Lewicki, H., Hahn, B., Shaw, G. & Oldstone, M. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103–6110 (1994).
  CAS PubMed PubMed Central Google Scholar
• Matano, T. et al. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72, 164–169 (1998).
  CAS PubMed PubMed Central Google Scholar
• Schmitz, J. E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857–860 (1999).
  Article CAS PubMed Google Scholar
• Jin, X. et al. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991–998 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Carrington, M. et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283, 1748–1752 (1999).
  Article CAS PubMed Google Scholar
• Ogg, G. S. et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103–2106 (1998).
  Article CAS PubMed Google Scholar
• Betts, M. R. et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75, 11983–11991 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Addo, M. M. et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77, 2081–2092 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Edwards, B. H. et al. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 76, 2298–2305 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Frahm, N. et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 78, 2187–2200 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Masemola, A. et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J. Virol. 78, 3233–3243 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hay, C. M. et al. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. J. Virol. 73, 5509–5519 (1999).
  CAS PubMed PubMed Central Google Scholar
• Draenert, R. et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J. Virol. 78, 630–641 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Goulder, P. J. R. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med. 3, 212–217 (1997). The evidence that CTL escape in a single epitope can precipitate loss of immune control in HIV infection.
  Article CAS PubMed Google Scholar
• Feeney, M. E. et al. Immune escape precedes breakthrough HIV-1 viremia and broadening of the CTL response in a HLA-B27-positive long-term non progressing child. J. Virol. (in the press).
• Kaslow, R. A. et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med. 2, 405–411 (1996).
  Article CAS PubMed Google Scholar
• Goulder, P. J. R. et al. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res. Hum. Retroviruses 12, 1691–1698 (1996).
  Article CAS PubMed Google Scholar
• O'Brien, S. J., Gao, X. & Carrington, M. HLA and AIDS: a cautionary tale. Trends Mol. Med. 7, 379–381 (2001).
  Article CAS PubMed Google Scholar
• Migueles, S. A. et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl Acad. Sci. USA 97, 2709–2714 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Tang, J. et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1 in Zambia. J. Virol. 76, 8276–8284 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Gao, X. et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344, 1668–1675 (2001).
  Article CAS PubMed Google Scholar
• Ho, D. D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).
  Article CAS PubMed Google Scholar
• Coffin, J. M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483–489 (1995).
  Article CAS PubMed Google Scholar
• Phillips, R. E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453–459 (1991).
  Article CAS PubMed Google Scholar
• Balter, M. Modest Briton stirs up storm with views on role of CTLs. Science 280, 1860–1861 (1998).
  Article CAS PubMed Google Scholar
• Meyerhans, A. et al. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur. J. Immunol. 21, 2637–2640 (1991).
  Article CAS PubMed Google Scholar
• Nietfeld, W. et al. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. J. Immunol. 154, 2189–2197 (1995).
  Google Scholar
• Chen, Z. W. et al. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J. Immunol. 149, 4060–4066 (1992).
  CAS PubMed Google Scholar
• Koenig, S. et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Med. 1, 330–336 (1995).
  Article CAS PubMed Google Scholar
• Borrow, P. et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3, 205–211 (1997).
  Article CAS PubMed Google Scholar
• Price, D. A. et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl Acad. Sci. USA 94, 1890–1895 (1997). References 32 and 33 provide evidence that acute escape in HIV infection precedes rapid progression.
  Article CAS PubMed PubMed Central Google Scholar
• Evans, D. T. et al. Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression. J. Virol. 74, 7400–7410 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Evans, D. T. et al. Virus-specific CTL responses select for amino acid variation in SIV Env and Nef. Nature Med. 5, 1270–1276 (1999).
  Article CAS PubMed Google Scholar
• Allen, T. M. et al. Tat-specific CTL select for SIV escape variants during resolution of primary viremia. Nature 407, 386–390 (2000). Extensive escape in acute SIV infection.
  Article CAS PubMed Google Scholar
• O'Connor, D. H. et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nature Med. 8, 493–499 (2002).
  Article CAS PubMed Google Scholar
• Friedrich, T. C. et al. Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J. Virol. 78, 2581–2585 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Peyerl, F. W. et al. Simian–human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope. J. Virol. 77, 12572–8 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Barouch, D. H. et al. Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J. Virol. 77, 7367–7375 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Moore, C. B. et al. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296, 1439–1443 (2002).
  Article CAS PubMed Google Scholar
• Barouch, D. H. et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335–339 (2002).
  Article CAS PubMed Google Scholar
• Wilson, J. D. et al. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 14, 225–233 (2000).
  Article CAS PubMed Google Scholar
• Kelleher, A. D. et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193, 375–386 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Gamble, T. R. et al. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87, 1285–1294 (1996).
  Article CAS PubMed Google Scholar
• Friedrich, T. C. et al. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nature Med. 10, 275–281 (2004).
  Article CAS PubMed Google Scholar
• Leslie, A. J. et al. HIV evolution: CTL escape mutation and reversion after transmission. Nature Med. 10, 282–289 (2004). References 46 and 47 describe reversion of CTL escape mutations following transmission to HLA-mismatched recipients and the possible implications.
  Article CAS PubMed Google Scholar
• Pal, R. et al. ALVAC-SIV-_gag_-_pol_-_env_-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVMAC-induced immunodeficiency. J. Virol. 76, 292–302 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Z. Q. et al. Mamu-A*01 allele-mediated attenuation of disease progression in simian–human immunodeficiency virus infection. J. Virol. 76, 12845–12854 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Mothe, B. R. et al. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVMAC239 replication. J. Virol. 77, 2736–2740 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• O'Connor, D. H. et al. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J. Virol. 77, 9029–9040 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Altfeld, M. et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17, 2581–2591 (2003).
  Article CAS PubMed Google Scholar
• Migueles, S. A. et al. The differential ability of HLA B*5701-positive long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 77, 6889–6898 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Matano, T. et al. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J. Exp. Med. 199, 1709–1718 (2004). Acute escape in a capsid-protein epitope is associated with reduced viral replicative capacity and subsequent immune-mediated suppression of SIV.
  Article CAS PubMed PubMed Central Google Scholar
• Goulder, P. J. R. et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193, 181–194 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Goulder, P. J. R. et al. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185, 1423–1433 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Brander, C. et al. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J. Clin. Invest. 101, 2559–2566 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Douek, D. C. et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168, 3099–3104 (2002).
  Article CAS PubMed Google Scholar
• Price, D. A. et al. Clonal structure of immunodominant CD8+ T cell responses in primary SIV infection. (Keystone Symposia, HIV Vaccine Development: Progress and Prospects, 12–18 April 2004) Abstract 326. (Whistler, Canada).
• Yang, O. O. et al. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J. Exp. Med. 197, 1365–1375 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, O. O. et al. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL. J. Immunol. 171, 3718–3724 (2003).
  Article CAS PubMed Google Scholar
• Van Baalen, C. A. et al. Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro. J. Virol. 72, 6851–6857 (1998).
  CAS PubMed PubMed Central Google Scholar
• Van Baalen, C. A. et al. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. Eur. J. Immunol. 32, 2644–2652 (2002).
  Article CAS PubMed Google Scholar
• Klenerman, P. & McMichael, A. J. HIV/AIDS. HLA leaves its footprints on HIV. Science 296, 1410–1411 (2002).
  Article PubMed Google Scholar
• Goulder, P. J. R. et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412, 334–338 (2001).
  Article CAS PubMed Google Scholar
• Klenerman, P. et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369, 403–407 (1994).
  Article CAS PubMed Google Scholar
• Davenport, M. P. Antagonists or altruists: do viral mutants modulate T-cell responses? Immunol. Today 16, 432–436 (1995).
  Article CAS PubMed Google Scholar
• Klenerman, P. & Zinkernagel, R. M. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394, 482–485 (1998).
  Article CAS PubMed Google Scholar
• McAdam, S. et al. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J. Immunol. 155, 2729–2736 (1995).
  CAS PubMed Google Scholar
• Draenert, R. et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 199, 905–915 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Allen, T. M. et al. Selection, transmission, and reversion of an antigen processing CTL escape mutation in HIV-1 Infection. J. Virol. 78, 7069–7078 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Serwold, T., Gonzalez, F., Kim, J., Jacob, R. & Shastri, N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419, 480–483 (2002).
  Article CAS PubMed Google Scholar
• Yokomaku, Y. et al. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. J. Virol. 78, 1324–1332 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397–401 (1998).
  Article CAS PubMed Google Scholar
• Le Gall, S. et al. Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. J. Virol. 74, 9256–9266 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Cohen, G. B. et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661–671 (1999).
  Article CAS PubMed Google Scholar
• Pantaleo, G. et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370, 463–467 (1994).
  Article CAS PubMed Google Scholar
• Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106–111 (2001).
  Article CAS PubMed Google Scholar
• Papagno, L. et al. Immune activation and CD8+ T cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2, 173–185 (2004).
  Article CAS Google Scholar
• Migueles, S. et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in non-progressors. Nature Immunol. 3, 1061–1068 (2002).
  Article CAS Google Scholar
• Gray, R. H. et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357, 1149–1153 (2001).
  Article CAS PubMed Google Scholar
• Gray, R. H. et al. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17, 1941–1951 (2003).
  Article PubMed Google Scholar
• Garcia, P. M. et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N. Engl. J. Med. 341, 394–402 (1999).
  Article CAS PubMed Google Scholar
• Burton, D. R. et al. HIV vaccine design and the neutralizing antibody problem. Nature Immunol. 5, 233–236 (2004).
  Article CAS Google Scholar
• Yewdell, J. W. & Bennink, J. R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17, 51–88 (1999).
  Article CAS PubMed Google Scholar
• Betts, M. M. et al. Lack of protection from HIV-1 infection by an HLA-B27-restricted anti-p24 Gag CD8+ T cell response induced by a recombinant HIV canarypox vaccine vector (vCP205). (Keystone Symposia, HIV Vaccine Development: Progress and Prospects, 12–18 April 2004) Abstract 205. (Whistler, Canada).
• Yang, O. O. Will we be able to 'spot' an effective HIV-1 vaccine? Trends Immunol. 24, 67–72 (2003).
  Article PubMed Google Scholar
• Ranki, A. & Krohn, K. J. E. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat, and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 139, 365–378 (1994).
  Article CAS PubMed Google Scholar
• Klotman, M. E. et al. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl Acad. Sci. USA 88, 5011–5015 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Pomerantz, R. J., Trono, D., Feinberg, M. B. & Baltimore, D. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61, 1271–1276 (1990).
  Article CAS PubMed Google Scholar
• Ali, A. et al. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J. Virol. 78, 561–567 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ali, A., et al. Broadly increased sensitivity to cytotoxic T lymphocytes resulting from nef epitope escape mutations. J. Immunol. 171, 3999–4005 (2003).
  Article CAS PubMed Google Scholar
• Altfeld, M. et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420, 434–439 (2002).
  Article CAS PubMed Google Scholar
• Rodriguez, F., Harkins, S., Slifka, M. K. & Whitton, J. L. Immunodominance in virus-induced CD8+ T-cell responses is dramatically modified by DNA immunization and is regulated by γ interferon. J. Virol. 76, 4251–4259 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Palmowski, M. J. et al. Competition between CTL narrows the immune response induced by prime–boost vaccination protocols. J. Immunol. 168, 4391–4398 (2002).
  Article CAS PubMed Google Scholar